Augmentation in patients with restless legs syndrome receiving pramipexole therapy: a retrospective study in a single center from China.
Tiantian WangMiaofa YingRui ZhaoDanyan ZhuLiSan ZhangPublished in: Sleep & breathing = Schlaf & Atmung (2021)
The augmentation rate of the Chinese RLS patients in our study was 15%. Augmentation may be associated with switching from other dopaminergic drugs, long disease duration before pramipexole use, the dose and duration of pramipexole, and tolerance to pramipexole.